The Synevo medical laboratory plans to launch innovative rapid tests for detecting the COVID-19 antigen declared by WHO in Ukraine in the coming weeks.
Mykola Butenko, the director of development at Synevo, told Interfax-Ukraine that at present, the company has brought an experimental batch of Austrian-made tests to Ukraine and is finishing their “internal” testing.
“Next week, we are already waiting for the delivery of these tests to launch testing for customers. The first delivery will be about 8,000 systems. If necessary, the manufacturer is ready to fully cover the needs of our network for these test systems, so tests will be performed across the entire Synevo network in Ukraine,” he said.
According to Butenko, the test manufacturer is a well-known Austrian company that specializes in the production of rapid tests for laboratory diagnostics. The test systems have passed clinical trials and are certified according to international standards.
“The huge advantage of these rapid tests is that their sensitivity is 97%, and the result will be ready in 15-30 minutes. Therefore, the use of such test systems for the COVID-19 antigen allows mass screening testing in a short time, which is very valuable in the conditions of uncontrolled growth of the epidemic,” he added.
The cost of the declared express tests for COVID-19 antigen in the Synevo network is about UAH 800.
